These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19697853)

  • 1. [Efficiency of lymphotropic intermittent chemotherapy in the complex treatment of patients with progressive pulmonary tuberculosis].
    Lysov AV; Nikonov SD; Kazakov AV; Red'kin IuV; Gaponenko GE; Burkova IV
    Tuberk Biolezni Legkih; 2009; (7):28-34. PubMed ID: 19697853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant lymphotrophic chemotherapy in the surgical treatment of progressive pulmonary tuberculosis].
    Kirillov IuV; El'kin AV; Kobak ME; Basek TS
    Tuberk Biolezni Legkih; 2009; (10):41-5. PubMed ID: 20000079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficiency of retrosternal lymphotropic chemotherapy in the treatment of new cases of destructive pulmonary tuberculosis].
    Kibrik BS; Zakharov AV
    Probl Tuberk Bolezn Legk; 2009; (4):23-7. PubMed ID: 19514450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined therapy of pulmonary tuberculosis by using recombinant interleukins].
    Skvortsova LA; Pavlova MV; Vinogradova TI; Archakova LI
    Probl Tuberk Bolezn Legk; 2003; (10):9-12. PubMed ID: 14669620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphotropic therapy in the combined treatment of pulmonary tuberculosis in children and adolescents].
    Lebedeva LV; Olianishin VN; Kadnikova ON
    Probl Tuberk; 1989; (5):26-8. PubMed ID: 2787506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical and pharmacokinetic features of lymphotropic therapy in patients with new-onset pulmonary tuberculosis].
    Priakhina VN; Kolpakov MA; Kolpakov AR; Zyrianova TV; Mokhina OG
    Probl Tuberk Bolezn Legk; 2005; (6):55-8. PubMed ID: 16078725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Roncoleukin in enhancing the efficiency of complex therapy for infiltrative pulmonary tuberculosis in adolescents].
    Barmina NA; Burukhina LV; Shurygin AA; Archakova LI
    Probl Tuberk Bolezn Legk; 2009; (5):27-31. PubMed ID: 19565809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of lymphotropic therapy in patients with tuberculosis in relations to genetic markers].
    Ubaĭdullaev AM; Belotserkovets VG; Kazakov KS
    Probl Tuberk; 2000; (6):44-6. PubMed ID: 11210834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrosternal lymphotropic chemotherapy and pneumoperitoneum in the treatment of drug-resistant destructive pulmonary tuberculosis].
    Kibrik BS; Zakharov AV; Lobanovskiĭ VM
    Probl Tuberk Bolezn Legk; 2009; (5):21-6. PubMed ID: 19565808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peribronchial lymphotropic therapy in the combined treatment of patients with progressive pulmonary tuberculosis].
    Pletnev GV; Krasnov DV
    Probl Tuberk Bolezn Legk; 2003; (12):3-5. PubMed ID: 15004961
    [No Abstract]   [Full Text] [Related]  

  • 11. [Optimization of indirect endolymphatic injection of isoniazid in pulmonary tuberculosis].
    Peleneva IM; Gariaeva NA; Burukhina LV; Zavgorodniĭ IG; Shurygin AA; Gorovits GA; Miroshnikova IP; Barlamov OP
    Probl Tuberk; 2002; (11):24-6. PubMed ID: 12501792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological correction in progressive pulmonary tuberculosis].
    Maslennikov AA; Kamenev VF; Kolomiets VM
    Probl Tuberk Bolezn Legk; 2007; (9):30-3. PubMed ID: 18038603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
    Ubaĭdullaev AM; Belotserkovets VG
    Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of isoniazid in once-weekly rifapentine treatment of pulmonary tuberculosis.
    Mitchison DA
    Am J Respir Crit Care Med; 2003 May; 167(10):1298-9. PubMed ID: 12738593
    [No Abstract]   [Full Text] [Related]  

  • 15. [Organization and methods of correcting the chemotherapy of destructive pulmonary tuberculosis].
    Kovalenko NI; Ginzburg TS; Shapovalov VP; Taranenko MI
    Probl Tuberk; 1987; (9):35-8. PubMed ID: 3422965
    [No Abstract]   [Full Text] [Related]  

  • 16. Spectrum of cytomorphology of tuberculous lymphadenitis and changes during anti-tubercular treatment.
    Sharma M; Agarwal S; Wadhwa N; Mishra K; Gadre DJ
    Cytopathology; 2007 Jun; 18(3):180-3. PubMed ID: 17388932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of short-term chemotherapy in patients with newly detected destructive pulmonary tuberculosis].
    Gol'dshtein VD; Komissarenko IB; Churilova RI; Kulik EI; Niamtsu EA
    Probl Tuberk; 1984 Jan; (1):29-34. PubMed ID: 6701168
    [No Abstract]   [Full Text] [Related]  

  • 18. [Enhancing treatment efficiency of patients with pulmonary tuberculosis by regional lymphotropic therapy].
    Ubaĭdullaev AM; Belotserkovskiĭ VG
    Probl Tuberk; 1999; (6):14-6. PubMed ID: 10715948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of maxaquin in the treatment of progressive pulmonary tuberculosis occurring with standard chemotherapy regimens].
    Mar'iandyshev AO; Klinberg NM; Shonbina AI; Moroz MI
    Probl Tuberk; 1997; (4):19-21. PubMed ID: 9333808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of acute progressive tuberculosis types].
    Khomenko AG; Mishin VI
    Probl Tuberk; 1996; (5):21-3. PubMed ID: 8984482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.